Sleep apnea is prevalent in as many as an estimated 18 million Canadians alone. This statistic denotes that approximately 1 in every 15 Canadian, or 6.62% of the total Canadian population have a case of sleep apnea. Two to four percent of all Canadians have an undiagnosed case of sleep apnea. This accounts for approximately 1 in 50 individuals being undiagnosed.
Regardless of the type of sleep disorder, the impact on individuals is considerable. Clinically, people suffering from sleep disorders have an increased likelihood of cardiovascular disease, hypertension and mortality. At the same time, these individuals experience reduced cognitive performance that lowers job performance, decreases their quality of life and makes them ten times more likely to be in an automobile accident. These individuals are more susceptible to work-related injuries, depression and family discord, too.
Economically, sleep disorders in Canada are estimated to cost $60 - $115 billion annually for medical and indirect expenses. Sleep studies and therapies alone cost an estimated $5 billion per year. Individuals with undiagnosed sleep disorders have also been documented as heavy users of medical services.
Seven types of sleep disorders occur most frequently in Canada. We have many treatments that can improve the symptoms of those disorders but they may be permanent problems. The disorders that you are looking at are conditions where a nerve may have an irreversible injury peripherally or in the CNS (brain) or the last one in the bone. We use low level or cold laser treatments in combination with medications and our appliance therapy to reduce symptoms and improve quality of life. The combination of treatment in this way usually reduces or sometimes eliminates the dosage of medications and therefore the side effects (drowsiness, fatigue, constipation, dizziness, etc), which in itself improves quality of life.
Sleep Apnea Syndrome, affecting an estimated 20 million individuals
Chronic/Severe Insomnia, affecting an estimated 20 million individuals
Circadian Rhythm Disorder, affecting an estimated 17 million individuals
RLS/PLMD: Restless Leg Syndrome / Periodic Limb Movement Disorder, affecting an estimated 10 million individuals
Parasomnia, affecting an estimated 3 million individuals
Cheyne-Stokes, affecting an estimated 1.5 million individuals
Narcolepsy, affecting an estimated 300,000 individuals